TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL RESPIRATORY DRUGS MARKET, BY DRUG CLASS
6.1. Overview
6.2. Short-Acting Beta2-Agonists (SABA)
6.3. Long-Acting Beta2-Agonists (LABA)
6.4. Inhaled Corticosteroids (ICS)
6.5. Anticholinergics
6.6. Antihistamines
6.7. Vasodilators
6.8. Combination Drugs
6.9. Others
7. GLOBAL RESPIRATORY DRUGS MARKET, BY DISEASE TYPE
7.1. Overview
7.2. Asthma
7.3. Chronic Bronchitis
7.4. Chronic Obstructive Pulmonary Disease (COPD)
7.5. Pleural Effusion
7.6. Others
8. GLOBAL RESPIRATORY DRUGS MARKET, BY ROUTE OF ADMINISTRATION
8.1. Overview
8.2. Inhalation
8.3. Enteral
8.4. Parenteral
9. GLOBAL RESPIRATORY DRUGS MARKET, BY DISTRIBUTION CHANNEL
9.1. Overview
9.2. Hospital Pharmacies
9.3. Retail Pharmacies
9.4. Online Pharmacies
10. GLOBAL RESPIRATORY DRUGS MARKET, BY REGION
10.1. Overview
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K
10.3.4. Italy
10.3.5. Spain
10.3.6. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. India
10.4.3. Japan
10.4.4. South Korea
10.4.5. Australia
10.4.6. Rest of Asia-Pacific
10.5. Rest of the World
10.5.1. Middle East
10.5.2. Africa
10.5.3. Latin America
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Global Respiratory Drugs Market,
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Global Respiratory Drugs Market,
11.7. Key developments and Growth Strategies
11.7.1. New Drug Class Launch/Disease Type Route of Administration
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales & Operating Income, 2022
11.8.2. Major Players R&D Expenditure. 2022
12. COMPANY PROFILES
12.1. VAPOTHERM
12.1.1. Company Overview
12.1.2. Financial Overview
12.1.3. Drug Classs Offered
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. AptarGroup, Inc.
12.2.1. Company Overview
12.2.2. Financial Overview
12.2.3. Drug Classs Offered
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. DRĂ„GERWERK AG & CO.
12.3.1. Company Overview
12.3.2. Financial Overview
12.3.3. Drug Classs Offered
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. Allied Healthcare
12.4.1. Company Overview
12.4.2. Financial Overview
12.4.3. Drug Classs Offered
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. Cardinal Health
12.5.1. Company Overview
12.5.2. Financial Overview
12.5.3. Drug Classs Offered
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. NSPIRE HEALTH INC.
12.6.1. Company Overview
12.6.2. Financial Overview
12.6.3. Drug Classs Offered
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. Philips N.V.
12.7.1. Company Overview
12.7.2. Financial Overview
12.7.3. Drug Classs Offered
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL RESPIRATORY DRUGS MARKET, SYNOPSIS, 2018-2032
TABLE 2 GLOBAL RESPIRATORY DRUGS MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL RESPIRATORY DRUGS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL RESPIRATORY DRUGS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL RESPIRATORY DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 6 GLOBAL RESPIRATORY DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 7 NORTH AMERICA RESPIRATORY DRUGS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 8 NORTH AMERICA RESPIRATORY DRUGS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 9 NORTH AMERICA RESPIRATORY DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 10 NORTH AMERICA RESPIRATORY DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 11 NORTH AMERICA RESPIRATORY DRUGS MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 12 U.S. RESPIRATORY DRUGS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 13 U.S. RESPIRATORY DRUGS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 14 U.S. RESPIRATORY DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 15 U.S. RESPIRATORY DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 16 CANADA RESPIRATORY DRUGS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 17 CANADA RESPIRATORY DRUGS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 18 CANADA RESPIRATORY DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 19 CANADA RESPIRATORY DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 20 EUROPE RESPIRATORY DRUGS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 21 EUROPE RESPIRATORY DRUGS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 22 EUROPE RESPIRATORY DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 23 EUROPE RESPIRATORY DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 24 EUROPE RESPIRATORY DRUGS MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 25 GERMANY RESPIRATORY DRUGS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 26 GERMANY RESPIRATORY DRUGS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 27 GERMANY RESPIRATORY DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 28 GERMANY RESPIRATORY DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 29 FRANCE RESPIRATORY DRUGS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 30 FRANCE RESPIRATORY DRUGS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 31 FRANCE RESPIRATORY DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 32 FRANCE RESPIRATORY DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 33 ITALY RESPIRATORY DRUGS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 34 ITALY RESPIRATORY DRUGS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 35 ITALY RESPIRATORY DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 36 ITALY RESPIRATORY DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 37 SPAIN RESPIRATORY DRUGS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 38 SPAIN RESPIRATORY DRUGS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 39 SPAIN RESPIRATORY DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 40 SPAIN RESPIRATORY DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 41 U.K RESPIRATORY DRUGS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 42 U.K RESPIRATORY DRUGS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 43 U.K RESPIRATORY DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 44 U.K RESPIRATORY DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 45 REST OF EUROPE RESPIRATORY DRUGS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 46 REST OF EUROPE RESPIRATORY DRUGS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 47 REST OF EUROPE RESPIRATORY DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 48 REST OF EUROPE RESPIRATORY DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 49 ASIA PACIFIC RESPIRATORY DRUGS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 50 ASIA PACIFIC RESPIRATORY DRUGS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 51 ASIA PACIFIC RESPIRATORY DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 52 ASIA PACIFIC RESPIRATORY DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 53 ASIA PACIFIC RESPIRATORY DRUGS MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 54 JAPAN RESPIRATORY DRUGS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 55 JAPAN RESPIRATORY DRUGS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 56 JAPAN RESPIRATORY DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 57 JAPAN RESPIRATORY DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 58 CHINA RESPIRATORY DRUGS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 59 CHINA RESPIRATORY DRUGS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 60 CHINA RESPIRATORY DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 61 CHINA RESPIRATORY DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 62 INDIA RESPIRATORY DRUGS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 63 INDIA RESPIRATORY DRUGS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 64 INDIA RESPIRATORY DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 65 INDIA RESPIRATORY DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 66 AUSTRALIA RESPIRATORY DRUGS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 67 AUSTRALIA RESPIRATORY DRUGS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 68 AUSTRALIA RESPIRATORY DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 69 AUSTRALIA RESPIRATORY DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 70 SOUTH KOREA RESPIRATORY DRUGS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 71 SOUTH KOREA RESPIRATORY DRUGS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 72 SOUTH KOREA RESPIRATORY DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 73 SOUTH KOREA RESPIRATORY DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 74 REST OF ASIA-PACIFIC RESPIRATORY DRUGS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 75 REST OF ASIA-PACIFIC RESPIRATORY DRUGS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 76 REST OF ASIA-PACIFIC RESPIRATORY DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 77 REST OF ASIA-PACIFIC RESPIRATORY DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 78 REST OF WORLD RESPIRATORY DRUGS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 79 REST OF WORLD RESPIRATORY DRUGS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 80 REST OF WORLD RESPIRATORY DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 81 REST OF WORLD RESPIRATORY DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 82 REST OF WORLD RESPIRATORY DRUGS MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 83 MIDDLE EAST RESPIRATORY DRUGS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 84 MIDDLE EAST RESPIRATORY DRUGS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 85 MIDDLE EAST RESPIRATORY DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 86 MIDDLE EAST RESPIRATORY DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 87 AFRICA RESPIRATORY DRUGS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 88 AFRICA RESPIRATORY DRUGS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 89 AFRICA RESPIRATORY DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 90 AFRICA RESPIRATORY DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 91 LATIN AMERICA RESPIRATORY DRUGS MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 92 LATIN AMERICA RESPIRATORY DRUGS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 93 LATIN AMERICA RESPIRATORY DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 94 LATIN AMERICA RESPIRATORY DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL RESPIRATORY DRUGS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL RESPIRATORY DRUGS MARKET
FIGURE 4 GLOBAL RESPIRATORY DRUGS MARKET, SHARE (%), BY DRUG CLASS, 2022
FIGURE 5 GLOBAL RESPIRATORY DRUGS MARKET, SHARE (%), BY DISEASE TYPE, 2022
FIGURE 6 GLOBAL RESPIRATORY DRUGS MARKET, SHARE (%), BY ROUTE OF ADMINISTRATION, 2022
FIGURE 7 GLOBAL RESPIRATORY DRUGS MARKET, SHARE (%), BY DISTRIBUTION CHANNEL, 2022
FIGURE 8 GLOBAL RESPIRATORY DRUGS MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 NORTH AMERICA: RESPIRATORY DRUGS MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 EUROPE: RESPIRATORY DRUGS MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 ASIA-PACIFIC: RESPIRATORY DRUGS MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 REST OF THE WORLD: RESPIRATORY DRUGS MARKET, SHARE (%), BY REGION, 2022
FIGURE 13 GLOBAL RESPIRATORY DRUGS MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 14 VAPOTHERM: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 VAPOTHERM: SWOT ANALYSIS
FIGURE 16 APTARGROUP, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 APTARGROUP, INC.: SWOT ANALYSIS
FIGURE 18 DRĂ„GERWERK AG & CO.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 DRĂ„GERWERK AG & CO.: SWOT ANALYSIS
FIGURE 20 ALLIED HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 ALLIED HEALTHCARE: SWOT ANALYSIS
FIGURE 22 CARDINAL HEALTH.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 CARDINAL HEALTH.: SWOT ANALYSIS
FIGURE 24 NSPIRE HEALTH INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 NSPIRE HEALTH INC.: SWOT ANALYSIS
FIGURE 26 PHILIPS N.V.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 PHILIPS N.V.: SWOT ANALYSIS
